Imaging Diagnostic Systems (fka IMDS)

[Cool_Trades]

$IMDS, SHIMADZU MEDICAL, & MISC INFO.:

Shimadzu Medical signing on is more than enough for the investor public to realize people want this product. Like any other developmental stage company out there, it takes money to make money. Well...IMDS is at the stage of making money, and then some...plain and simple, and that's where investors want to jump in. A company of the magnitude of Shimadzu does not do business with failing companies....read their latest annual filing like I have and you'll see Shimadzu Corp. out of Japan grossed US$1.2 billion in PROFIT just last year, and as of last March had US$375 million in CASH. For one this throws all the scam arguments out the window, and two, it only verifies in my mind that IMDS is far from a failing company.

$756,000 was due on June 30th, otherwise it would have converted into, as you said, 50-70 percent discounted shares. What we KNOW from the price action thus far is that there is no newly issued shares hitting the market, which means the company took care of the debt one way or another.

Give it about until mid July...

The same folks who said this statement were the ones saying ALL last month there was dilution, now it seems you're saying it'll happen later??? Investing 101: TO MAINTAIN THE SAME MARKET CAP, THE PRICE PER SHARE MUST DROP TO MAINTAIN THE SAME MARKET CAP. That means stock prices don't oscillate sideways let alone RISE on lower volume like the chart clearly stipulates. That throws all dilution claims out the window.

If the company received 3rd party financing, I'd imagine then would file an 8k for that which since the company offices are closed today in observance of the July 4 holiday, we may not see that till next, BUT the only other option given no 8k AND no dilution is that an extension was granted for the payment which does not require an 8k, and with Shimadzu actively updating their website and applying to Australia's government FOR IMDS in order to sell the unit in that region, count on revenues from sales of the CTLM being enough to overcome first their immediate $756,000 debt and then the rest of the $4-5 million they needed to go in front of the FDA and to pay off any other immediate debt, including the IRS. Btw...the IRS has been involved for over a year, and the company as stated in their filings has special counsel taking care of the issue already, hence why the IRS hasn't ceased operations in over a year despite the fact they have the ability to do so.

Each CTLM sells at a retail price of $495,000. Their Chinese distributor is under contract to purchase 15 units within this year, and they have sold only 1 of the 5 units to Mexico because the construction of the hospital in Mexico has not been completed yet. If one does the math, that alone is more than enough revenues to pay off the immediate debt as well as undergo the FDA approval process.

Not to mention as of last March per the latest quarterly report, the CTLM is responsible for 25,000 scans worldwide from those 17 units you mentioned.

IMO, it's a very wild claim to suggest people don't want this product when Shimadzu updated their website just yesterday and the CTLM is actively in use in 17 countries, INCLUDING the USA despite FDA approval will be granted in the fall of this year. There is a unit actively in use at the University of Florida.